Drug intelligence / Profile preview

AVERSION-F

Development stage
Unknown
Lead developer
Martia Laboratories
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

AVERSION-F is a combination ophthalmic suspension developed by Martia Laboratories for the treatment of bacterial eye infections accompanied by inflammation. It contains tobramycin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, and fluorometholone, a synthetic glucocorticoid corticosteroid that reduces inflammatory responses by inhibiting the production of prostaglandins and other mediators. This topical formulation is indicated for conditions such as conjunctivitis, keratitis, and post-operative ocular inflammation, providing both antimicrobial action and symptomatic relief from redness and swelling.

Brand names
AVERSION-FAVERSION-F Eye Drops
Other names
Tobramycin + Fluorometholone Ophthalmic Suspension
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on AVERSION-F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVERSION-F.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call